Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Pharmadrug Inc C.PHRX

Alternate Symbol(s):  LMLLF

Medical Care Cannabis
PharmaDrug Inc. is a Canada-based specialty pharmaceutical company. The Company is focused on the research, development and commercialization of controlled-substances and natural medicines, such as psychedelics and previously approved drugs. The Company’s subsidiary, Sairiyo Therapeutics (Sairiyo), is a biotech company that specializes in researching and reformulating established natural medicines. Sairiyo is engaged in the development of its patented reformulation of cepharanthine, a drug that has shown substantial third party validated potential for the treatment of infectious diseases and rare cancers. Sairiyo is also conducting research and development (R&D) in the psychedelics space for the treatment of non-neuropsychiatric conditions. The Company also operates through SecureDose Synthetics Inc., which is a pharmaceutical research and development company focused on the development of synthetic formulations of existing drugs for potential commercialization and distribution.


CSE:PHRX - Post by User

Pharmadrug Inc > Stop trashing each other. Let’s talk about buzz
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(3076)
•••
Comment by Goldy63on Apr 14, 2021 10:50am
36 Views
Post# 32992499

RE:RE:RE:Stop trashing each other. Let’s talk about buzz

RE:RE:RE:Stop trashing each other. Let’s talk about buzz
SamRothstein wrote: I'm glad you mentioned that LyingWhisperer.  Maybe that is in fact Jeff's plan.  To try and drive the price down as low as possible with his 9 month long campaign of false statements.  And you have been bashing Buzz for almost as long as Jeff.   Hmmm.

 
LionWhisperer wrote: If it is the most undervalued company why did the CEO sell day before the news and of course the huge amount paid for the aquisition of a basically empty storefront.......Its going back to the price it started maybe lower.Unless Jeff buys this company out and cleans it up but aI do not advise this as its not worth anything to him


Well we all know LW da skinless likes to short so humm yah same time line as Jeff so double humm . Long Buzz. 

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities